Related Experiment Video
Updated: Jul 3, 2026

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model
Published on: April 17, 2026
Quercetin-induced ubiquitination and down-regulation of Her-2/neu
Jae-Hoon Jeong1, Jee Young An, Yong Tae Kwon
1Department of Surgery, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA.
Abstract:
Her-2/neu (ErbB2) is a transmembrane tyrosine kinase and acts as a co-receptor for the other EGFR family members. It is well known that high expression of Her-2/neu is associated with a poor prognosis in breast cancer. Quercetin, a flavonoid present in many vegetables and fruits, has been studied extensively as a chemoprevention agent in several cancer models. In this study, we observed that quercetin decreased the level of Her-2/neu protein in time- and dose-dependent manners and also inhibited the downstream survival PI3K-Akt signaling pathway in Her-2/neu-overexpressing breast cancer SK-Br3 cells. We also observed that quercetin induced polyubiquitination of Her-2/neu. When the proteasome pathway was blocked by MG-132 during quercetin treatment, accumulation of the NP-40 insoluble form of Her-2/neu occurred. Interestingly, data from immunocomplex studies revealed that quercetin promoted interaction between Her-2/neu and Hsp90 which is a molecular chaperone involved in stabilization of Her-2/neu. In this condition, inhibition of Hsp90 activity by a specific inhibitor, geldanamycin (GA), or intracellular ATP depletion caused dissociation of Hsp90 from Her-2/neu and promoted ubiquitination and down-regulation of Her-2/neu protein. In addition, the carboxyl terminus of Hsc70-interacting protein (CHIP), a chaperone-dependent E3 ubiquitin ligase, played a crucial role in the quercetin-induced ubiquitination of Her-2/neu. Inhibition of tyrosine kinase activity of Her-2/neu by quercetin could indicate an lateration in the Her-2/neu structure which promotes CHIP recruitments and down-regulation of Her-2/neu. We believe that by using quercetin, new therapeutic strategies can be developed to treat Her-2/neu overexpressing cancers.
Insights
Quercetin, a natural flavonoid, reduces Her-2/neu protein levels in breast cancer cells by promoting its ubiquitination and proteasomal degradation. This suggests quercetin as a potential therapeutic agent for Her-2/neu-overexpressing cancers.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Her-2/neu (ErbB2) overexpression is linked to poor prognosis in breast cancer.
- Quercetin is a flavonoid with studied chemopreventive properties.
Purpose of the Study:
- To investigate the effect of quercetin on Her-2/neu protein levels and signaling pathways in breast cancer cells.
- To elucidate the mechanism by which quercetin downregulates Her-2/neu.
Main Methods:
- Treatment of Her-2/neu-overexpressing SK-Br3 cells with quercetin.
- Analysis of Her-2/neu protein levels, ubiquitination, and downstream signaling (PI3K-Akt pathway).
- Inhibition of proteasome and Hsp90 pathways to study Her-2/neu degradation.
Main Results:
- Quercetin decreased Her-2/neu protein in a time- and dose-dependent manner.
- Quercetin induced Her-2/neu polyubiquitination and promoted its interaction with Hsp90 and CHIP.
- Inhibition of Hsp90 or proteasome pathways affected Her-2/neu stability and degradation.
Conclusions:
- Quercetin downregulates Her-2/neu protein through a mechanism involving Hsp90, CHIP, and the proteasome.
- Quercetin's ability to target Her-2/neu suggests its potential as a therapeutic strategy for relevant cancers.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
GPCR Desensitization
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Export of Misfolded Proteins out of the ER
Mitogens and the Cell Cycle
